The effect of takinib, a small molecule inhibitor of TAK1,[21] as well as 5Z‐7‐oxozeaenol, a natural compound that acts as a potent TAK1 inhibitor,[22] was tested in several human and murine HCC cell lines. Here, MAP3K7 is linked to hepatocellular carcinoma.